Skip to main content
Clinical Trials/NCT07475507
NCT07475507Active, not recruitingNot Applicable

Effect of PEEK and Titanium Framework Reinforcement on Marginal Bone Loss Around Implants Supporting a Fixed All-on-four Prosthesis in Completely Edentulous Mandibles. A Randomized Controlled Clinical Trial

Cairo University1 site in 1 country20 target enrollmentStarted: August 1, 2024Last updated:
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
20
Locations
1
Primary Endpoint
Marginal bone loss

Study Overview

Brief Summary

A fixed all-on-four prosthesis will be constructed for the lower arch for each patient and the marginal bone loss will be evaluated at baseline, 3,6,9 and 12 months.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
45 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Completely edentulous patients requesting a fixed, implant supported restoration.
  • Patients aged from 45 to 60, able to sign an informed consent will be considered eligible for this trial.
  • Implant sites must allow the placement of four implants.
  • Non- heavy Smokers will be included (smoking up to 10 cigarettes/day)
  • In case of post-extraction sites, they must have been healed for at least 3 months before being treated in the study.
  • Patients with no systemic condition that may interfere with implant placement (e.g., Immunosuppressed or immunocompromised patients, patients under treatment of intravenous amino-bisphosphonates)

Exclusion Criteria

  • Patients with poor oral hygiene and motivation.
  • Female patients taking any medical treatment for management of osteoporosis.
  • Drug abusers.
  • Psychiatric problems or unrealistic expectations.
  • Patients with active infection or inflammation in the planned implant area at the time of implant placement.
  • Immuno-compromised patients (Diabetic with HBA1C > 7 or patients undergoing chemo or radiotherapy or bisphosphonates)

Arms & Interventions

Titanium framework reinforced all on four prosthesis

Other

Active Comparator: Titanium reinforced fixed all-on-four prosthesis

Intervention: Titanium framework reinforced all on four prosthesis (Other)

PEEK framework reinforced all on four prosthesis

Other

Intervention: PEEK framework reinforced all on four prosthesis (Other)

Outcomes

Primary Outcomes

Marginal bone loss

Time Frame: 12 months at intervals (0,3,6,9and 12 months)

Marginal bone loss around each dental implant using parallel technique in digital periodical radiographs which will be measured in mm from the crestal bone level at the implant platform.

Secondary Outcomes

  • Bone density(12 months at intervals (0,3,6,9and 12 months))

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ahmed Mohamed Hamed Khalaf

Assistant lecturer of Prosthodontics

Cairo University

Study Sites (1)

Loading locations...

Similar Trials

Effect of PEEK and Titanium Framework... | Clinical Trial